-
1
-
-
77950346282
-
Immunity, inflammation, and cancer
-
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
-
(2010)
Cell
, vol.140
, pp. 883-899
-
-
Grivennikov, S.I.1
Greten, F.R.2
Karin, M.3
-
2
-
-
30144443269
-
Paradoxical roles of the immune system during cancer development
-
de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6:24-37.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 24-37
-
-
De Visser, K.E.1
Eichten, A.2
Coussens, L.M.3
-
3
-
-
84927732725
-
Regulation of inflammasome activation
-
Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev 2015;265:6-21.
-
(2015)
Immunol Rev
, vol.265
, pp. 6-21
-
-
Man, S.M.1
Kanneganti, T.D.2
-
4
-
-
85040956314
-
NLRP1 polymorphisms in patients with asbestos-associated mesothelioma
-
Girardelli M, Maestri I, Rinaldi RR, Tognon M, Boldorini R, Bovenzi M, et al. NLRP1 polymorphisms in patients with asbestos-associated mesothelioma. Infect Agent Cancer 2012;7:25.
-
(2012)
Infect Agent Cancer
, vol.7
, pp. 25
-
-
Girardelli, M.1
Maestri, I.2
Rinaldi, R.R.3
Tognon, M.4
Boldorini, R.5
Bovenzi, M.6
-
5
-
-
84862646126
-
Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma
-
Verma D, Bivik C, Farahani E, Synnerstad I, Fredrikson M, Enerback C, et al. Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res 2012;25:506-13.
-
(2012)
Pigment Cell Melanoma Res
, vol.25
, pp. 506-513
-
-
Verma, D.1
Bivik, C.2
Farahani, E.3
Synnerstad, I.4
Fredrikson, M.5
Enerback, C.6
-
6
-
-
84988622178
-
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation
-
Zhong FL, Mamai O, Sborgi L, Boussofara L, Hopkins R, Robinson K, et al. Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell 2016;167:187-202e17.
-
(2016)
Cell
, vol.167
, pp. 187-202
-
-
Zhong, F.L.1
Mamai, O.2
Sborgi, L.3
Boussofara, L.4
Hopkins, R.5
Robinson, K.6
-
7
-
-
84868626486
-
Genetic variation and alterations of genes involved in NFkappaB/TNFAIP3-and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer
-
Ungerback J, Belenki D, Jawad ul-Hassan A, Fredrikson M, Fransen K, Elander N, et al. Genetic variation and alterations of genes involved in NFkappaB/TNFAIP3-and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer. Carcinogenesis 2012;33: 2126-34.
-
(2012)
Carcinogenesis
, vol.33
, pp. 2126-2134
-
-
Ungerback, J.1
Belenki, D.2
Jawad Ul-Hassan, A.3
Fredrikson, M.4
Fransen, K.5
Elander, N.6
-
8
-
-
84887924524
-
The landscape of microsatellite instability in colorectal and endometrial cancer genomes
-
Kim TM, Laird PW, Park PJ. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell 2013;155:858-68.
-
(2013)
Cell
, vol.155
, pp. 858-868
-
-
Kim, T.M.1
Laird, P.W.2
Park, P.J.3
-
9
-
-
78049488908
-
IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation
-
Zaki MH, Vogel P, Body-Malapel M, Lamkanfi M, Kanneganti TD. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 2010;185: 4912-20.
-
(2010)
J Immunol
, vol.185
, pp. 4912-4920
-
-
Zaki, M.H.1
Vogel, P.2
Body-Malapel, M.3
Lamkanfi, M.4
Kanneganti, T.D.5
-
10
-
-
77952303410
-
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
-
Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 2010;207:1045-56.
-
(2010)
J Exp Med
, vol.207
, pp. 1045-1056
-
-
Allen, I.C.1
TeKippe, E.M.2
Woodford, R.M.3
Uronis, J.M.4
Holl, E.K.5
Rogers, A.B.6
-
11
-
-
77950002937
-
The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis
-
Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010;32:379-91.
-
(2010)
Immunity
, vol.32
, pp. 379-391
-
-
Zaki, M.H.1
Boyd, K.L.2
Vogel, P.3
Kastan, M.B.4
Lamkanfi, M.5
Kanneganti, T.D.6
-
12
-
-
79955846705
-
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis
-
Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, et al. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 2011;17:1359-72.
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 1359-1372
-
-
Hirota, S.A.1
Ng, J.2
Lueng, A.3
Khajah, M.4
Parhar, K.5
Li, Y.6
-
13
-
-
77956128040
-
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
-
Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 2010;59:1192-9.
-
(2010)
Gut
, vol.59
, pp. 1192-1199
-
-
Bauer, C.1
Duewell, P.2
Mayer, C.3
Lehr, H.A.4
Fitzgerald, K.A.5
Dauer, M.6
-
14
-
-
78650735879
-
Inflammationinduced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
-
Hu B, Elinav E, Huber S, Booth CJ, Strowig T, Jin C, et al. Inflammationinduced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci U S A 2010;107:21635-40.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 21635-21640
-
-
Hu, B.1
Elinav, E.2
Huber, S.3
Booth, C.J.4
Strowig, T.5
Jin, C.6
-
15
-
-
77949965210
-
Control of intestinal homeostasis, colitis, and colitisassociated colorectal cancer by the inflammatory caspases
-
Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KS, McIntire CR, LeBlanc PM, et al. Control of intestinal homeostasis, colitis, and colitisassociated colorectal cancer by the inflammatory caspases. Immunity 2010;32:367-78.
-
(2010)
Immunity
, vol.32
, pp. 367-378
-
-
Dupaul-Chicoine, J.1
Yeretssian, G.2
Doiron, K.3
Bergstrom, K.S.4
McIntire, C.R.5
LeBlanc, P.M.6
-
16
-
-
77955350419
-
MyD88-mediated signaling prevents development of adenocarcinomas of the colon: Role of interleukin 18
-
Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med 2010;207:1625-36.
-
(2010)
J Exp Med
, vol.207
, pp. 1625-1636
-
-
Salcedo, R.1
Worschech, A.2
Cardone, M.3
Jones, Y.4
Gyulai, Z.5
Dai, R.M.6
-
17
-
-
0041426439
-
Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice
-
Takagi H, Kanai T, Okazawa A, Kishi Y, Sato T, Takaishi H, et al. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand J Gastroenterol 2003;38:837-44.
-
(2003)
Scand J Gastroenterol
, vol.38
, pp. 837-844
-
-
Takagi, H.1
Kanai, T.2
Okazawa, A.3
Kishi, Y.4
Sato, T.5
Takaishi, H.6
-
18
-
-
84925850795
-
The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis
-
Williams TM, Leeth RA, Rothschild DE, Coutermarsh-Ott SL, McDaniel DK, Simmons AE, et al. The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis. J Immunol 2015;194:3369-80.
-
(2015)
J Immunol
, vol.194
, pp. 3369-3380
-
-
Williams, T.M.1
Leeth, R.A.2
Rothschild, D.E.3
Coutermarsh-Ott, S.L.4
McDaniel, D.K.5
Simmons, A.E.6
-
19
-
-
84945444876
-
The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity
-
Dupaul-Chicoine J, Arabzadeh A, Dagenais M, Douglas T, Champagne C, Morizot A, et al. The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity. Immunity 2015;43:751-63.
-
(2015)
Immunity
, vol.43
, pp. 751-763
-
-
Dupaul-Chicoine, J.1
Arabzadeh, A.2
Dagenais, M.3
Douglas, T.4
Champagne, C.5
Morizot, A.6
-
20
-
-
79959540809
-
A functional role for Nlrp6 in intestinal inflammation and tumorigenesis
-
Chen GY, Liu M, Wang F, Bertin J, Nunez G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol 2011;186: 7187-94.
-
(2011)
J Immunol
, vol.186
, pp. 7187-7194
-
-
Chen, G.Y.1
Liu, M.2
Wang, F.3
Bertin, J.4
Nunez, G.5
-
21
-
-
79957576718
-
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis
-
Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011;145:745-57.
-
(2011)
Cell
, vol.145
, pp. 745-757
-
-
Elinav, E.1
Strowig, T.2
Kau, A.L.3
Henao-Mejia, J.4
Thaiss, C.A.5
Booth, C.J.6
-
22
-
-
79959369355
-
Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury
-
Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, Peyrin-Biroulet L, et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci USA 2011;108:9601-6.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 9601-9606
-
-
Normand, S.1
Delanoye-Crespin, A.2
Bressenot, A.3
Huot, L.4
Grandjean, T.5
Peyrin-Biroulet, L.6
-
23
-
-
84976310851
-
A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion
-
Birchenough GM, Nystrom EE, Johansson ME, Hansson GC. A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science 2016;352:1535-42.
-
(2016)
Science
, vol.352
, pp. 1535-1542
-
-
Birchenough, G.M.1
Nystrom, E.E.2
Johansson, M.E.3
Hansson, G.C.4
-
24
-
-
84868615556
-
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
-
Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012;491:259-63.
-
(2012)
Nature
, vol.491
, pp. 259-263
-
-
Huber, S.1
Gagliani, N.2
Zenewicz, L.A.3
Huber, F.J.4
Bosurgi, L.5
Hu, B.6
-
25
-
-
70350569295
-
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1betadependent adaptive immunity against tumors
-
Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1betadependent adaptive immunity against tumors. Nat Med 2009;15:1170-8.
-
(2009)
Nat Med
, vol.15
, pp. 1170-1178
-
-
Ghiringhelli, F.1
Apetoh, L.2
Tesniere, A.3
Aymeric, L.4
Ma, Y.5
Ortiz, C.6
-
26
-
-
84896691062
-
NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion
-
Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 2014;156:1045-59.
-
(2014)
Cell
, vol.156
, pp. 1045-1059
-
-
Wlodarska, M.1
Thaiss, C.A.2
Nowarski, R.3
Henao-Mejia, J.4
Zhang, J.P.5
Brown, E.M.6
-
27
-
-
84924706729
-
Epithelial NAIPs protect against colonic tumorigenesis
-
Allam R, Maillard MH, Tardivel A, Chennupati V, Bega H, Yu CW, et al. Epithelial NAIPs protect against colonic tumorigenesis. J Exp Med 2015; 212:369-83.
-
(2015)
J Exp Med
, vol.212
, pp. 369-383
-
-
Allam, R.1
Maillard, M.H.2
Tardivel, A.3
Chennupati, V.4
Bega, H.5
Yu, C.W.6
-
28
-
-
84869206979
-
NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases
-
Chow MT, Sceneay J, Paget C, Wong CS, Duret H, Tschopp J, et al. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res 2012;72:5721-32.
-
(2012)
Cancer Res
, vol.72
, pp. 5721-5732
-
-
Chow, M.T.1
Sceneay, J.2
Paget, C.3
Wong, C.S.4
Duret, H.5
Tschopp, J.6
-
29
-
-
84991608477
-
NLRC4 suppresses melanoma tumor progression independently of inflammasome activation
-
Janowski AM, Colegio OR, Hornick EE, McNiff JM, Martin MD, Badovinac VP, et al. NLRC4 suppresses melanoma tumor progression independently of inflammasome activation. J Clin Invest 2016;126:3917-3928.
-
(2016)
J Clin Invest
, vol.126
, pp. 3917-3928
-
-
Janowski, A.M.1
Colegio, O.R.2
Hornick, E.E.3
McNiff, J.M.4
Martin, M.D.5
Badovinac, V.P.6
-
30
-
-
84934346989
-
Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer
-
Man SM, Zhu Q, Zhu L, Liu Z, Karki R, Malik A, et al. Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer. Cell 2015;162:45-58.
-
(2015)
Cell
, vol.162
, pp. 45-58
-
-
Man, S.M.1
Zhu, Q.2
Zhu, L.3
Liu, Z.4
Karki, R.5
Malik, A.6
-
31
-
-
84938996802
-
Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt
-
Wilson JE, Petrucelli AS, Chen L, Koblansky AA, Truax AD, Oyama Y, et al. Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt. Nat Med 2015;21:906-13.
-
(2015)
Nat Med
, vol.21
, pp. 906-913
-
-
Wilson, J.E.1
Petrucelli, A.S.2
Chen, L.3
Koblansky, A.A.4
Truax, A.D.5
Oyama, Y.6
-
32
-
-
78650360196
-
The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells
-
van Deventer HW, Burgents JE, Wu QP, Woodford RM, Brickey WJ, Allen IC, et al. The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells. Cancer Res 2010;70:10161-9.
-
(2010)
Cancer Res
, vol.70
, pp. 10161-10169
-
-
Van Deventer, H.W.1
Burgents, J.E.2
Wu, Q.P.3
Woodford, R.M.4
Brickey, W.J.5
Allen, I.C.6
-
33
-
-
54549089856
-
Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice
-
Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 2008;14:408-19.
-
(2008)
Cancer Cell
, vol.14
, pp. 408-419
-
-
Tu, S.1
Bhagat, G.2
Cui, G.3
Takaishi, S.4
Kurt-Jones, E.A.5
Rickman, B.6
-
34
-
-
84872607356
-
Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma
-
Liu W, Luo Y, Dunn JH, Norris DA, Dinarello CA, Fujita M. Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma. J Invest Dermatol 2013;133:518-27.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 518-527
-
-
Liu, W.1
Luo, Y.2
Dunn, J.H.3
Norris, D.A.4
Dinarello, C.A.5
Fujita, M.6
-
35
-
-
84868529740
-
Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis
-
Drexler SK, Bonsignore L, Masin M, Tardivel A, Jackstadt R, Hermeking H, et al. Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci USA 2012;109:18384-9.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. 18384-18389
-
-
Drexler, S.K.1
Bonsignore, L.2
Masin, M.3
Tardivel, A.4
Jackstadt, R.5
Hermeking, H.6
-
36
-
-
35448954376
-
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression
-
Bunt SK, Yang L, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 2007;67:10019-26.
-
(2007)
Cancer Res
, vol.67
, pp. 10019-10026
-
-
Bunt, S.K.1
Yang, L.2
Sinha, P.3
Clements, V.K.4
Leips, J.5
Ostrand-Rosenberg, S.6
-
37
-
-
84872086179
-
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
-
Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F, et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med 2013;19:57-64.
-
(2013)
Nat Med
, vol.19
, pp. 57-64
-
-
Bruchard, M.1
Mignot, G.2
Derangere, V.3
Chalmin, F.4
Chevriaux, A.5
Vegran, F.6
-
38
-
-
84990848498
-
Obesityassociated NLRC4 inflammasome activation drives breast cancer progression
-
Kolb R, Phan L, Borcherding N, Liu Y, Yuan F, Janowski AM, et al. Obesityassociated NLRC4 inflammasome activation drives breast cancer progression. Nat Commun 2016;7:13007.
-
(2016)
Nat Commun
, vol.7
, pp. 13007
-
-
Kolb, R.1
Phan, L.2
Borcherding, N.3
Liu, Y.4
Yuan, F.5
Janowski, A.M.6
-
39
-
-
84949309790
-
Epithelial IL-18 equilibrium controls barrier function in colitis
-
Nowarski R, Jackson R, Gagliani N, de Zoete MR, Palm NW, Bailis W, et al. Epithelial IL-18 equilibrium controls barrier function in colitis. Cell 2015;163:1444-56.
-
(2015)
Cell
, vol.163
, pp. 1444-1456
-
-
Nowarski, R.1
Jackson, R.2
Gagliani, N.3
De Zoete, M.R.4
Palm, N.W.5
Bailis, W.6
-
40
-
-
84923107393
-
Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection
-
Munoz M, Eidenschenk C, Ota N, Wong K, Lohmann U, Kuhl AA, et al. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity 2015;42:321-31.
-
(2015)
Immunity
, vol.42
, pp. 321-331
-
-
Munoz, M.1
Eidenschenk, C.2
Ota, N.3
Wong, K.4
Lohmann, U.5
Kuhl, A.A.6
-
41
-
-
80051698136
-
IL-18 induces PD-1-dependent immunosuppression in cancer
-
Terme M, Ullrich E, Aymeric L, Meinhardt K, Desbois M, Delahaye N, et al. IL-18 induces PD-1-dependent immunosuppression in cancer. Cancer Res 2011;71:5393-9.
-
(2011)
Cancer Res
, vol.71
, pp. 5393-5399
-
-
Terme, M.1
Ullrich, E.2
Aymeric, L.3
Meinhardt, K.4
Desbois, M.5
Delahaye, N.6
-
42
-
-
77951240589
-
Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome
-
Juliana C, Fernandes-Alnemri T, Wu J, Datta P, Solorzano L, Yu JW, et al. Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J Biol Chem 2010;285: 9792-802.
-
(2010)
J Biol Chem
, vol.285
, pp. 9792-9802
-
-
Juliana, C.1
Fernandes-Alnemri, T.2
Wu, J.3
Datta, P.4
Solorzano, L.5
Yu, J.W.6
-
43
-
-
84924415042
-
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
-
Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 2015;21:248-55.
-
(2015)
Nat Med
, vol.21
, pp. 248-255
-
-
Coll, R.C.1
Robertson, A.A.2
Chae, J.J.3
Higgins, S.C.4
Munoz-Planillo, R.5
Inserra, M.C.6
-
44
-
-
70449727077
-
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
-
Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, Deshayes K, et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 2009;187:61-70.
-
(2009)
J Cell Biol
, vol.187
, pp. 61-70
-
-
Lamkanfi, M.1
Mueller, J.L.2
Vitari, A.C.3
Misaghi, S.4
Fedorova, A.5
Deshayes, K.6
-
45
-
-
84055182560
-
The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes
-
Coll RC, Robertson A, Butler M, Cooper M, O'Neill LA. The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS One 2011;6:e29539.
-
(2011)
PLoS One
, vol.6
, pp. e29539
-
-
Coll, R.C.1
Robertson, A.2
Butler, M.3
Cooper, M.4
O'Neill, L.A.5
-
46
-
-
77749327591
-
Thalidomide inhibits activation of caspase-1
-
Keller M, Sollberger G, Beer HD. Thalidomide inhibits activation of caspase-1. J Immunol 2009;183:5593-9.
-
(2009)
J Immunol
, vol.183
, pp. 5593-5599
-
-
Keller, M.1
Sollberger, G.2
Beer, H.D.3
-
47
-
-
23444439667
-
IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients
-
Stack JH, Beaumont K, Larsen PD, Straley KS, Henkel GW, Randle JC, et al. IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J Immunol 2005;175:2630-4.
-
(2005)
J Immunol
, vol.175
, pp. 2630-2634
-
-
Stack, J.H.1
Beaumont, K.2
Larsen, P.D.3
Straley, K.S.4
Henkel, G.W.5
Randle, J.C.6
-
48
-
-
61449122079
-
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component
-
Lust JA, Lacy MQ, Zeldenrust SR, Dispenzieri A, Gertz MA, Witzig TE, et al. Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component. Mayo Clin Proc 2009;84:114-22.
-
(2009)
Mayo Clin Proc
, vol.84
, pp. 114-122
-
-
Lust, J.A.1
Lacy, M.Q.2
Zeldenrust, S.R.3
Dispenzieri, A.4
Gertz, M.A.5
Witzig, T.E.6
-
49
-
-
49449094892
-
A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome
-
Goldbach-Mansky R, Shroff SD, Wilson M, Snyder C, Plehn S, Barham B, et al. A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum 2008;58: 2432-42.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 2432-2442
-
-
Goldbach-Mansky, R.1
Shroff, S.D.2
Wilson, M.3
Snyder, C.4
Plehn, S.5
Barham, B.6
-
50
-
-
77953665294
-
Canakinumab
-
Dhimolea E. Canakinumab. MAbs 2010;2:3-13.
-
(2010)
MAbs
, vol.2
, pp. 3-13
-
-
Dhimolea, E.1
-
51
-
-
0032983336
-
Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response
-
Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999;10:127-36.
-
(1999)
Immunity
, vol.10
, pp. 127-136
-
-
Novick, D.1
Kim, S.H.2
Fantuzzi, G.3
Reznikov, L.L.4
Dinarello, C.A.5
Rubinstein, M.6
-
52
-
-
85019406841
-
NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer
-
Karki R, Man SM, Malireddi RK, Kesavardhana S, Zhu Q, Burton AR, et al. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature 2016;540:583-7.
-
(2016)
Nature
, vol.540
, pp. 583-587
-
-
Karki, R.1
Man, S.M.2
Malireddi, R.K.3
Kesavardhana, S.4
Zhu, Q.5
Burton, A.R.6
-
53
-
-
84856988610
-
Simultaneous targeting of toll-and nod-like receptors induces effective tumor-specific immune responses
-
Garaude J, Kent A, van Rooijen N, Blander JM. Simultaneous targeting of toll-and nod-like receptors induces effective tumor-specific immune responses. Sci Transl Med 2012;4:120ra16.
-
(2012)
Sci Transl Med
, vol.4
, pp. 120ra16
-
-
Garaude, J.1
Kent, A.2
Van Rooijen, N.3
Blander, J.M.4
|